Acta Ophthalmol

1. STOKHOLM L, Pedersen FN, Andersen N, Andresen J, et al
   Presence and development of diabetic retinopathy in 16 999 patients with type 1 diabetes in the Danish Registry of Diabetic Retinopathy.
   Acta Ophthalmol. 2024 May 18. doi: 10.1111/aos.16707.
   

   >> Share

   
   

   
   Am J Cardiol

2. CASTIELLO DS, Piccolo R, Esposito G
   Is diabetes still a risk factor for PCI-related outcomes in the era of imaging-guided PCI?
   Am J Cardiol. 2024 May 22:S0002-9149(24)00392.
   

   >> Share

   
   

   
   Am J Nephrol

3. MOLONEY BM, Chertow GM, Mc Causland FR
   Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
   Am J Nephrol. 2024 May 23. doi: 10.1159/000539451.
   

   >> Share

   
   

   
   Ann Intern Med

4. MARUTHUR NM, Pilla SJ, White K, Wu B, et al
   Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity : A Randomized Controlled Trial.
   Ann Intern Med. 2024;177:549-558.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

5. APTE M, Zambre S, Pisar P, Roy B, et al
   Decoding the role of aldosterone in glycation-induced diabetic complications.
   Biochem Biophys Res Commun. 2024;721:150107.
   

   >> Share

   
   
6. ZENG X, Zhang Y, Tian L, Zheng Y, et al
   Mitigation of ROS-triggered endoplasmic reticulum stress by upregulating Nrf2 retards diabetic nephropathy.
   Biochem Biophys Res Commun. 2024;721:149972.
   

   >> Share

   
   
7. LI P, Fang RL, Wang W, Zeng XX, et al
   Apigenin suppresses epithelial-mesenchymal transition in high glucose-induced retinal pigment epithelial cell by inhibiting CBP/p300-mediated histone acetylation.
   Biochem Biophys Res Commun. 2024;717:150061.
   

   >> Share

   
   

   
   BMC Pediatr

8. HASHIM AS, Al-Obaidi MN, Al-Obaidi AD, Saleh SA, et al
   "An unprecedented occurrence: a case report of pulmonary hypertension manifestation in Donohue syndrome".
   BMC Pediatr. 2024;24:327.
   

   >> Share

   
   

   
   Br J Ophthalmol

9. JIN G, Ma Y, Zheng D, Jin L, et al
   Evaluation of systemic medications associated with diabetic retinopathy: a nested case-control study from the UK Biobank.
   Br J Ophthalmol. 2024 May 20:bjo-2023-324930. doi: 10.1136/bjo-2023-324930.
   

   >> Share

   
   
10. MELLOR J, Jiang W, Fleming A, McGurnaghan SJ, et al
    Prediction of retinopathy progression using deep learning on retinal images within the Scottish screening programme.
    Br J Ophthalmol. 2024 Feb 5:bjo-2023-323400. doi: 10.1136/bjo-2023-323400.
    

    >> Share

    
    
11. BRESSLER I, Aviv R, Margalit D, Rom Y, et al
    Autonomous screening for laser photocoagulation in fundus images using deep learning.
    Br J Ophthalmol. 2024;108:742-746.
    

    >> Share

    
    

    
    Diabet Med

12. ALFARWAN N, Hodkinson A, Panagioti M, Hassan L, et al
    Clinical and cost-effectiveness of telemedicine among patients with type 2 diabetes in primary care: A systematic review and meta-analysis.
    Diabet Med. 2024 May 23:e15343. doi: 10.1111/dme.15343.
    

    >> Share

    
    

    
    Diabetes

13. JIANG Y, Yang J, Xia L, Wei T, et al
    Gut Microbiota-Tryptophan Metabolism-GLP-1 Axis Participates in beta-Cell Regeneration Induced by Dapagliflozin.
    Diabetes. 2024;73:926-940.
    

    >> Share

    
    
14. PESCHARD S, Raverdy V, Bauvin P, Goutchtat R, et al
    Genetic Evidence of Causal Relation Between Intestinal Glucose Absorption and Early Postprandial Glucose Response: A Mendelian Randomization Study.
    Diabetes. 2024;73:983-992.
    

    >> Share

    
    
15. PATAKY MW, Nair KS
    Response to Comment on Pataky et al. Divergent Skeletal Muscle Metabolomic Signatures of Different Exercise Training Modes Independently Predict Cardiometabolic Risk Factors. Diabetes 2024;73:23-37.
    Diabetes. 2024;73:e4-e5.
    

    >> Share

    
    
16. CHEN X, Tripathy D, Chilton R, Hansis-Diarte A, et al
    Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.
    Diabetes. 2024;73:896-902.
    

    >> Share

    
    
17. YANG Z, Zhang Z, Li L, Jing Z, et al
    Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-onset Type 1 Diabetes.
    Diabetes. 2024 May 21:db230987. doi: 10.2337/db23-0987.
    

    >> Share

    
    
18. LEE CS, Shang R, Wang F, Khayambashi P, et al
    Heparanase Stimulation of Physiological Cardiac Hypertrophy is Suppressed Following Chronic Diabetes Resulting in Cardiac Remodeling and Dysfunction.
    Diabetes. 2024 May 21:db240217. doi: 10.2337/db24-0217.
    

    >> Share

    
    
19. SHILLO P, Sloan G, Selvarajah D, Greig M, et al
    Reduced Thalamic Gamma Aminobutyric Acid (GABA) in Painless but not Painful Diabetic Peripheral Neuropathy.
    Diabetes. 2024 May 22:db230921. doi: 10.2337/db23-0921.
    

    >> Share

    
    

    
    Diabetes Care

20. SELVIN E
    The Glucose Management Indicator: Time to Change Course?
    Diabetes Care. 2024;47:906-914.
    

    >> Share

    
    
21. BERGENSTAL RM, Beck RW
    The Glucose Management Indicator: Time to Change Course? Diabetes Care 2024;47:906-914.
    Diabetes Care. 2024;47:e48-e49.
    

    >> Share

    
    
22. PAGE B
    About the Editor: Jeremy Pettus, MD: A Multipronged Approach for Managing Type 1 Diabetes.
    Diabetes Care. 2024;47:902-903.
    

    >> Share

    
    
23. OGUNGBE O, Yeh HC, Cooper LA
    Living Within the Redlines: How Structural Racism and Redlining Shape Diabetes Disparities.
    Diabetes Care. 2024;47:927-929.
    

    >> Share

    
    
24. BOEDER SC, Thomas RL, Le Roux MJ, Giovannetti ER, et al
    Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.
    Diabetes Care. 2024 May 22:dc240212. doi: 10.2337/dc24-0212.
    

    >> Share

    
    
25. SHEN Y, Jiang L, Xie X, Meng X, et al
    Long-Term Exposure to Fine Particulate Matter and Fasting Blood Glucose and Diabetes in 20 Million Chinese Women of Reproductive Age.
    Diabetes Care. 2024 May 22:dc232153. doi: 10.2337/dc23-2153.
    

    >> Share

    
    
26. KAHKOSKA AR, Busby-Whitehead J, Jonsson Funk M, Pratley RE, et al
    Receipt of Diabetes Specialty Care and Management Services by Older Adults With Diabetes in the United States, 2015-2019: An Analysis of Medicare Fee-for-Service Claims.
    Diabetes Care. 2024 May 22:dc231982. doi: 10.2337/dc23-1982.
    

    >> Share

    
    
27. KATZ A, Roy-Fleming A, Housni A, Talbo MK, et al
    The Support-Pro Online Training Platform: Increasing Health Care Professionals' Confidence and Knowledge in Treating People Living With Type 1 Diabetes.
    Diabetes Care. 2024 May 23:dc240302. doi: 10.2337/dc24-0302.
    

    >> Share

    
    
28. STAUSHOLM MB, Siersma V, Koster-Rasmussen R, Waagepetersen A, et al
    Increased Risk of Tendon Injury Following Structured Care in Patients With Type 2 Diabetes: Post Hoc Analysis of a Large Randomized Controlled Trial With 19 Years of Follow-up.
    Diabetes Care. 2024 May 23:dc240330. doi: 10.2337/dc24-0330.
    

    >> Share

    
    
29. KOEFOED AS, Knorr S, Fuglsang J, Leth-Moller M, et al
    Hemoglobin A1c Trajectories During Pregnancy and Adverse Outcomes in Women With Type 2 Diabetes: A Danish National Population-Based Cohort Study.
    Diabetes Care. 2024 May 21:dc232304. doi: 10.2337/dc23-2304.
    

    >> Share

    
    
30. DONAGHUE KC, Liew G
    Measuring Outcomes of Diabetic Retinopathy Screening: What Is Important?
    Diabetes Care. 2024;47:930-932.
    

    >> Share

    
    
31. DUAN D, Mathioudakis NN, Pilla SJ
    Treatment of Diabetes in Hospitals With Noninsulin Medications Is a Research Priority.
    Diabetes Care. 2024;47:915-917.
    

    >> Share

    
    
32. LIMBERT C, Kowalski AJ, Danne TPA
    Automated Insulin Delivery: A Milestone on the Road to Insulin Independence in Type 1 Diabetes.
    Diabetes Care. 2024;47:918-920.
    

    >> Share

    
    
33. RAYMAN G
    Enhancing Perioperative Diabetes Care: Strategies and Challenges.
    Diabetes Care. 2024;47:921-923.
    

    >> Share

    
    

    
    Diabetes Obes Metab

34. BAILEY CJ
    Metformin: Therapeutic profile in the treatment of type 2 diabetes.
    Diabetes Obes Metab. 2024 May 24. doi: 10.1111/dom.15663.
    

    >> Share

    
    
35. BUCKLEY A, Suliman S, Allum M, Mohammed N, et al
    Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population.
    Diabetes Obes Metab. 2024 May 24. doi: 10.1111/dom.15680.
    

    >> Share

    
    
36. WANG D, Chen Z, Wu Y, Ren J, et al
    Association between two novel anthropometric measures and type 2 diabetes in a Chinese population.
    Diabetes Obes Metab. 2024 May 24. doi: 10.1111/dom.15651.
    

    >> Share

    
    
37. SUN Y, Li W, Zhou Y, Wang B, et al
    Long-term changes in frailty and incident type 2 diabetes: A prospective cohort study based on the UK Biobank.
    Diabetes Obes Metab. 2024 May 24. doi: 10.1111/dom.15676.
    

    >> Share

    
    
38. SVENSSON CH, Fabricius TW, Verhulst CEM, Kristensen PL, et al
    Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
    Diabetes Obes Metab. 2024 May 22. doi: 10.1111/dom.15649.
    

    >> Share

    
    
39. SUGIMOTO T, Saji N, Omura T, Tokuda H, et al
    Cross-sectional association of continuous glucose monitoring-derived metrics with cerebral small vessel disease in older adults with type 2 diabetes.
    Diabetes Obes Metab. 2024 May 19. doi: 10.1111/dom.15659.
    

    >> Share

    
    
40. TSUKAMOTO S, Kobayashi K, Toyoda M, Tone A, et al
    Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
    Diabetes Obes Metab. 2024 May 19. doi: 10.1111/dom.15652.
    

    >> Share

    
    

    
    Diabetologia

41. SHEU A, White CP, Center JR
    Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
    

    >> Share

    
    
42. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
    

    >> Share

    
    
43. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
    

    >> Share

    
    
44. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
    

    >> Share

    
    
45. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
    Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
    

    >> Share

    
    
46. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
    Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
    

    >> Share

    
    
47. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
    Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
    

    >> Share

    
    
48. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
    Heterogeneity of glycaemic phenotypes in type 1 diabetes.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
    

    >> Share

    
    
49. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
    The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
    

    >> Share

    
    

    
    J Am Soc Nephrol

50. VELICKOVIC D, Shapiro JP, Parikh SV, Rovin B, et al
    Protein N-glycans in Healthy and Sclerotic Glomeruli in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2024 May 21. doi: 10.1681/ASN.0000000000000393.
    

    >> Share

    
    

    
    J Autoimmun

51. POYSTI S, Silojarvi S, Brodnicki TC, Catterall T, et al
    Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    J Autoimmun. 2023;140:103090.
    

    >> Share

    
    
52. KISHIMOTO TK, Fournier M, Michaud A, Rizzo G, et al
    Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
    J Autoimmun. 2023;140:103125.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

53. TRIOLO TM, Parikh HM, Tosur M, Ferrat L, et al
    Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives.
    J Clin Endocrinol Metab. 2024 May 20:dgae349. doi: 10.1210.
    

    >> Share

    
    
54. 
    Correction to: "Dose-dependent Association of Alcohol Consumption With Obesity and Type 2 Diabetes: Mendelian Randomization Analyses".
    J Clin Endocrinol Metab. 2024 May 23:dgae343. doi: 10.1210.
    

    >> Share

    
    

    
    JAMA

55. DIXIT AA, Bateman BT, Hawn MT, Odden MC, et al
    Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;331:1672-1673.
    

    >> Share

    
    

    
    Kidney Int

56. MCEVOY CM, Yuen DA
    Not too much, not too little-just the right amount: the story of YAP in the podocyte.
    Kidney Int. 2024;105:1157-1159.
    

    >> Share

    
    
57. NANGAKU M
    SGLT2 inhibitor: 2-way superstar in nephrology?
    Kidney Int. 2024;105:1176-1177.
    

    >> Share

    
    
58. KUME S, Packer M
    SGLT2 inhibitors act as metabolic transducers to restore healthy nutrient deprivation and surplus signaling in the kidney.
    Kidney Int. 2024;105:1172-1176.
    

    >> Share

    
    
59. YAU K, Cherney DZI, van Raalte DH, Wever BE, et al
    Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect.
    Kidney Int. 2024;105:1168-1172.
    

    >> Share

    
    

    
    Lancet

60. ADLER AI, Coleman RL, Leal J, Whiteley WN, et al
    Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
    Lancet. 2024 May 17:S0140-6736(24)00537-3. doi: 10.1016/S0140-6736(24)00537.
    

    >> Share

    
    

    
    N Engl J Med

61. PERKOVIC V, Tuttle KR, Rossing P, Mahaffey KW, et al
    Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMoa2403347.
    

    >> Share

    
    

    
    Obstet Gynecol

62. PADGETT CE, Ye Y, Champion ML, Fleenor RE, et al
    Continuous Glucose Monitoring for Management of Type 2 Diabetes and Perinatal Outcomes.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005609.
    

    >> Share

    
    

    
    Pediatr Diabetes

63. KUBOTA-MISHRA E, Huang X, Minard CG, Astudillo M, et al
    High Prevalence of A(-)beta(+) Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT).
    Pediatr Diabetes. 2024;2024:5907924.
    

    >> Share

    
    

    
    PLoS One

64. YORKE E, Akpalu J, de-Graft Johnson G, Atiase Y, et al
    A national audit of facilities, human and material resources for the comprehensive management of diabetes in Ghana-A 2023 update.
    PLoS One. 2024;19:e0303624.
    

    >> Share

    
    
65. ABDUL-SAMED AB, Peprah EB, Jahan Y, Reichenberger V, et al
    Exploring the path to optimal diabetes care by unravelling the contextual factors affecting access, utilisation, and quality of primary health care in West Africa: A scoping review protocol.
    PLoS One. 2024;19:e0294917.
    

    >> Share

    
    
66. SAIRAT K, Phoosuwan N
    Factors associated with oral health care behavior of people with type 2 diabetes mellitus: A hospital-based, cross-sectional study.
    PLoS One. 2024;19:e0303530.
    

    >> Share

    
    
67. HATSEK A, Hochberg I, Daoud Naccache D, Biderman A, et al
    Design of a bi-directional methodology for automated assessment of compliance to continuous application of clinical guidelines, and its evaluation in the type 2 diabetes domain.
    PLoS One. 2024;19:e0303542.
    

    >> Share

    
    
68. KHAN AQ, Sun G, Khalid M, Imran A, et al
    A novel fusion of genetic grey wolf optimization and kernel extreme learning machines for precise diabetic eye disease classification.
    PLoS One. 2024;19:e0303094.
    

    >> Share

    
    
69. K BANDA C, Banda NPK, Gombachika BT, Nyirenda MJ, et al
    Primary health care preparedness to integrate diabetes care in Blantyre, Malawi: A mixed methods study.
    PLoS One. 2024;19:e0303030.
    

    >> Share

    
    
70. WANG S, Zhao S, Jin S, Ye T, et al
    Sepsis risk in diabetic patients with urinary tract infection.
    PLoS One. 2024;19:e0303557.
    

    >> Share

    
    
71. AMARAVADI SK, Maiya GA, K V, Shastry BA, et al
    Effectiveness of structured exercise program on insulin resistance and quality of life in type 2 diabetes mellitus-A randomized controlled trial.
    PLoS One. 2024;19:e0302831.
    

    >> Share

    
    
72. REBALKA IA, Noguchi KS, Bulyovsky KR, Badour MI, et al
    Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.
    PLoS One. 2024;19:e0303448.
    

    >> Share

    
    
73. OHKUMA T, Iwase M, Kitazono T
    Sleep duration and its association with constipation in patients with diabetes: The fukuoka diabetes registry.
    PLoS One. 2024;19:e0302430.
    

    >> Share

    
    
74. COBB J, Rawson J, Gonzalez N, Orr C, et al
    Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
    PLoS One. 2024;19:e0303863.
    

    >> Share

    
    
75. CREMER T, Hoelen H, van de Weijer ML, Janssen GM, et al
    Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.
    PLoS One. 2024;19:e0287877.
    

    >> Share

    
    
76. TANTHANATHEWIN R, Wongrattanapipat W, Khaing TT, Aimmanee P, et al
    Automatic exudate and aneurysm segmentation in OCT images using UNET++ and hyperreflective-foci feature based bagged tree ensemble.
    PLoS One. 2024;19:e0304146.
    

    >> Share

    
    
77. CHEN S, Ling Y, Zhou F, Qiao X, et al
    Trajectories of cognitive function among people aged 45 years and older living with diabetes in China: Results from a nationally representative longitudinal study (2011~2018).
    PLoS One. 2024;19:e0299316.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

78. WANG S, Zhang Y, Zhong Y, Xue Y, et al
    Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle-mRNA formulation.
    Proc Natl Acad Sci U S A. 2024;121:e2322935121.
    

    >> Share

    
    

    
    Retina

79. WANG M, Shao Y, Gong Y, Liu B, et al
    ASSOCIATION OF MACULAR STRUCTURE WITH MICROPERIMETRY SENSITIVITY FOLLOWING VITRECTOMY FOR PROLIFERATE DIABETIC RETINOPATHY.
    Retina. 2024;44:982-990.
    

    >> Share

    
    
80. FICKWEILER W, Chokshi T, Jangolla S, Mitzner M, et al
    CLINICAL CHARACTERIZATION OF AQUEOUS AND VITREOUS RETINOL-BINDING PROTEIN 3 CONCENTRATIONS IN RELATION TO DIABETIC RETINOPATHY SEVERITY, RETINAL STRUCTURES, AND SYSTEMIC COMPLICATIONS.
    Retina. 2024;44:1026-1033.
    

    >> Share

    
    

    
    Transplant Proc

81. ROSSI MR, Mazzali M, de Sousa MV
    Oral Glucose Tolerance Test as a Risk Marker for Developing Post-Transplant Diabetes Mellitus.
    Transplant Proc. 2024 May 17:S0041-1345(24)00259.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share